[Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001572:Benzofurans / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D006073:Gout / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets; D013997:Time Factors; D014527:Uric Acid / Q000097:blood / Q000652:urine
D000893:Anti-Inflammatory Agents; D001572:Benzofurans; D013607:Tablets; D014527:Uric Acid
Klinische und biologische Wirkung einer neuen harnsäuresenkenden Substanz (Benziodaronum) bei der Gicht. Ergebnis einer zweijährigen Untersuchung.